Literature DB >> 19028958

Microglia: gatekeepers of central nervous system immunology.

Bart R Tambuyzer1, Peter Ponsaerts, Etienne J Nouwen.   

Abstract

Microglia are perhaps the most underestimated cell type of our immune system. Not only were immunologists unaware of their capabilities until recently, but also, some neuroscientists denied their actual existence until the late 20th century. Nowadays, their presence is confirmed extensively, as demonstrated by numerous reports describing their involvement in virtually all neuropathologies. However, despite distinct approaches, their origin remains a point of controversy. Although many agree about their myeloid-monocytic ancestry, the precise progenitor cells and the differentiation mechanisms, which give rise to microglia in the different developmental stages of the CNS, are not unraveled yet. Mostly, this can be attributed to their versatile phenotype. Indeed, microglia show a high morphological plasticity, which is related to their functional state. This review about microglia aims to introduce the reader extensively into their ontogeny, cell biology, and involvement in different neuropathologies.

Entities:  

Mesh:

Year:  2008        PMID: 19028958     DOI: 10.1189/jlb.0608385

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  130 in total

1.  Estrogen and P2 Purinergic Receptor Systems in Microglia: Therapeutic Targets for Neuroprotection.

Authors:  Jessica M Crain; Jyoti J Watters
Journal:  Open Drug Discov J       Date:  2010-01-01

Review 2.  The myeloid cells of the central nervous system parenchyma.

Authors:  Richard M Ransohoff; Astrid E Cardona
Journal:  Nature       Date:  2010-11-11       Impact factor: 49.962

3.  Endotoxin-induced systemic inflammation activates microglia: [¹¹C]PBR28 positron emission tomography in nonhuman primates.

Authors:  Jonas Hannestad; Jean-Dominique Gallezot; Thomas Schafbauer; Keunpoong Lim; Tracy Kloczynski; Evan D Morris; Richard E Carson; Yu-Shin Ding; Kelly P Cosgrove
Journal:  Neuroimage       Date:  2012-07-06       Impact factor: 6.556

4.  Arginine deprivation and immune suppression in a mouse model of Alzheimer's disease.

Authors:  Matthew J Kan; Jennifer E Lee; Joan G Wilson; Angela L Everhart; Candice M Brown; Andrew N Hoofnagle; Marilyn Jansen; Michael P Vitek; Michael D Gunn; Carol A Colton
Journal:  J Neurosci       Date:  2015-04-15       Impact factor: 6.167

5.  Autophagy regulates MAVS signaling activation in a phosphorylation-dependent manner in microglia.

Authors:  Jinbo Cheng; Yajin Liao; Lei Xiao; Rong Wu; Siqi Zhao; Hong Chen; Baidong Hou; Xia Zhang; Chengyu Liang; Yun Xu; Zengqiang Yuan
Journal:  Cell Death Differ       Date:  2016-11-04       Impact factor: 15.828

6.  Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells.

Authors:  Emily S Wires; David Alvarez; Curtis Dobrowolski; Yun Wang; Marisela Morales; Jonathan Karn; Brandon K Harvey
Journal:  J Neurovirol       Date:  2012-05-22       Impact factor: 2.643

Review 7.  Vaccination in the immunotherapy of glioblastoma.

Authors:  Ziren Kong; Yu Wang; Wenbin Ma
Journal:  Hum Vaccin Immunother       Date:  2017-12-11       Impact factor: 3.452

Review 8.  Innate immune responses to HIV infection in the central nervous system.

Authors:  Rebeca Geffin; Micheline McCarthy
Journal:  Immunol Res       Date:  2013-12       Impact factor: 2.829

9.  Differential expression of doublecortin and microglial markers in the rat brain following fractionated irradiation.

Authors:  Sona Balentova; Eva Hajtmanova; Marian Adamkov; Jan Lehotsky
Journal:  Neurochem Res       Date:  2014-12-09       Impact factor: 3.996

10.  Chemokine fractalkine attenuates overactivation and apoptosis of BV-2 microglial cells induced by extracellular ATP.

Authors:  Fei Hao; Nan-Nan Zhang; Dong-Mei Zhang; Hui-Yu Bai; Hua Piao; Bo Yuan; Hao-Yue Zhu; Huan Yu; Cong-Shu Xiao; Ai-Ping Li
Journal:  Neurochem Res       Date:  2013-02-28       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.